MedPath

EMA Approvals

European Medicines Agency approved drug marketing authorisations and regulatory information

European Medicines Agency
European Union
1,717 Approvals
Showing 101 to 120 of 1,717 approvalsPage 6 of 86

Fabhalta

Authorisation: May 17, 2024

Awiqli

Authorisation: May 17, 2024

Jubbonti

Authorisation: May 16, 2024

Omlyclo

Authorisation: May 16, 2024

Omlyclo

Authorisation: May 16, 2024

Omlyclo

Authorisation: May 16, 2024

Emblaveo

Authorisation: Apr 22, 2024

Nintedanib Accord

Authorisation: Apr 19, 2024

Pyzchiva

Authorisation: Apr 19, 2024

Pyzchiva

Authorisation: Apr 19, 2024

Incellipan

Authorisation: Apr 19, 2024

Voydeya

Authorisation: Apr 19, 2024

Voydeya

Authorisation: Apr 19, 2024

Celldemic

Authorisation: Apr 19, 2024

Filspari

Authorisation: Apr 19, 2024

Tizveni

Authorisation: Apr 19, 2024

Apremilast Accord

Authorisation: Apr 19, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.